![51njRwmo+xL._CLa|610,500|51bQc1b-beL.jpg,412eKjMrvOL.jpg|0,0,277,500+333,0,277,500+138,0,333,500_._SY300_.jpg 51njRwmo+xL._CLa|610,500|51bQc1b-beL.jpg,412eKjMrvOL.jpg|0,0,277,500+333,0,277,500+138,0,333,500_._SY300_.jpg](https://m.media-amazon.com/images/I/51njRwmo+xL._CLa%7C610,500%7C51bQc1b-beL.jpg,412eKjMrvOL.jpg%7C0,0,277,500+333,0,277,500+138,0,333,500_._SY300_.jpg)
51njRwmo+xL._CLa|610,500|51bQc1b-beL.jpg,412eKjMrvOL.jpg|0,0,277,500+333,0,277,500+138,0,333,500_._SY300_.jpg
![PDF) Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes PDF) Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes](https://i1.rgstatic.net/publication/338013944_Refractory_Epstein-Barr_Virus_EBV-Related_Post-transplant_Lymphoproliferative_Disease_Cure_by_Combined_Brentuximab_Vedotin_and_Allogeneic_EBV-Specific_T-Lymphocytes/links/5dfa2f66a6fdcc283729060b/largepreview.png)
PDF) Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
![Newspaper Image 26 of The journal (New York [NY]), June 28, 1896, (SUNDAY JOURNAL SUMMER RESORT SUPPLEMENT) Newspaper Image 26 of The journal (New York [NY]), June 28, 1896, (SUNDAY JOURNAL SUMMER RESORT SUPPLEMENT)](http://tile.loc.gov/image-services/iiif/service:sgp:sgpbatches:batch_dlc_archibald_ver01:data:sn84031792:print2432:1896062801:0590/full/pct:6.25/0/default.jpg)
Newspaper Image 26 of The journal (New York [NY]), June 28, 1896, (SUNDAY JOURNAL SUMMER RESORT SUPPLEMENT)
![41--ae6bvML._CLa|612,500|31f1dL2KSVL.jpg,41d5b8slU0L.jpg|0,0,278,500+334,0,278,500+139,0,334,500_._SY300_.jpg 41--ae6bvML._CLa|612,500|31f1dL2KSVL.jpg,41d5b8slU0L.jpg|0,0,278,500+334,0,278,500+139,0,334,500_._SY300_.jpg](https://m.media-amazon.com/images/I/41--ae6bvML._CLa%7C612,500%7C31f1dL2KSVL.jpg,41d5b8slU0L.jpg%7C0,0,278,500+334,0,278,500+139,0,334,500_._SY300_.jpg)
41--ae6bvML._CLa|612,500|31f1dL2KSVL.jpg,41d5b8slU0L.jpg|0,0,278,500+334,0,278,500+139,0,334,500_._SY300_.jpg
![91emzNWVLhL._CLa|3059,2560|91KQ+1QZ-lL.jpg,91irErcDwIL.jpg|0,0,1390,2560+1669,0,1390,2560+695,0,1669,2560_._SY200_.jpg 91emzNWVLhL._CLa|3059,2560|91KQ+1QZ-lL.jpg,91irErcDwIL.jpg|0,0,1390,2560+1669,0,1390,2560+695,0,1669,2560_._SY200_.jpg](https://m.media-amazon.com/images/I/91emzNWVLhL._CLa%7C3059,2560%7C91KQ+1QZ-lL.jpg,91irErcDwIL.jpg%7C0,0,1390,2560+1669,0,1390,2560+695,0,1669,2560_._SY200_.jpg)